These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6622515)

  • 21. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
    Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J
    Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol.
    Kostrzewa RM; Saleh MI
    Brain Res Dev Brain Res; 1989 Jan; 45(1):95-101. PubMed ID: 2645067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT; Matsokis NA; Valcana T
    J Neurosci Res; 1993 Aug; 35(5):499-506. PubMed ID: 8377223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
    Beckstead RM
    Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
    Leslie CA; Bennett JP
    Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3- and 4-O-sulfoconjugated and methylated dopamine: highly reduced binding affinity to dopamine D2 receptors in rat striatal membranes.
    Werle E; Lenz T; Strobel G; Weicker H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):28-34. PubMed ID: 2853303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of specificity and stereoselectivity of rat brain dopamine receptors.
    Miller JC; Friedhoff AJ
    Int J Dev Neurosci; 1986; 4(1):21-6. PubMed ID: 2458672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action.
    LaHoste GJ; Marshall JF
    Brain Res; 1989 Nov; 502(2):223-32. PubMed ID: 2531015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 105(1-2):171-4. PubMed ID: 6149143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of neuroleptic binding characteristics in rat striatum and renal cortex.
    Hietala J; Syvälahti E; Röyttä M
    J Recept Res; 1988; 8(6):753-71. PubMed ID: 3193400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution.
    Caboche J; Rogard M; Besson MJ
    Brain Res Dev Brain Res; 1991 Jan; 58(1):111-22. PubMed ID: 1849802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affinity shifts induced by cations do not reliably predict the agonistic or antagonistic nature of ligands at brain dopamine receptors.
    Urwyler S
    J Neurochem; 1987 Nov; 49(5):1415-20. PubMed ID: 2959751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of right middle cerebral artery occlusion on striatal dopaminergic function.
    Materossi C; Maoret T; Rozzini R; Spano PF; Trabucchi M
    J Neural Transm; 1982; 53(4):257-64. PubMed ID: 7108507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.